IRCT20230222057495N17招募中Unknown
Bioequivalence study of Tablet Esomeprazole 40 mg of Koushan Pharmed pharmaceutical company compared to the sample of Esomeprazole 40 mg of AstraZeneca Company in Sweden on healthy volunteers
Koushan Pharmed Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Healthy volunteers aged between 18 and 55 years.
- •Body mass index less than 30 kg per square meter.
- •All candidates must be non-smokers.
排除标准
- •Blood pressure less than 90 on 60 mm Hg or more than 140 on 90 mm Hg.
- •Consumption of any drug, alcohol or tobacco within 2 weeks before receiving the drug.
研究者
相似试验
尚未招募
不适用
Bio equivalence study of Esomeprazole 40 mgBio equivalence Esomeprazole 40 mg.IRCT20200513047423N3Sina pishgam daru novin24
尚未招募
4 期
Bioequivalence study of esomeprazole 20 mg (Capsule vs Tablet) in healthy Thai volunteers under fasting and fed conditionsHealthy volunteersTCTR20201125002Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University89
尚未招募
不适用
Bioequivalence study of manufactured by Esmoprazole 40mg Cap. Kooshan Pharmed. Co. (Eosoflux) in Iranian healthy volunteersIRCT20200105046010N7Tabriz University of Medical Sciences24
已完成
1 期
A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy ParticipantsHealthy ParticipantsNCT03083639Takeda52
已完成
4 期
Bioequivalence of Two Formulations of EsomeprazoleHealthyNCT02543606Yung Shin Pharm. Ind. Co., Ltd.14